HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This phase IV trial studies how well human papillomavirus (HPV) vaccine therapy works in interrupting progression in patients with high-grade vulvar or anal lesions. Vaccines made from HPV peptides or antigens may help the body build an effective immune response to kill tumor cells and decrease the chance of vulvar or anal lesions to progress or come back.
Epistemonikos ID: 5039121983223997976663bfa162a8dbbc6b42e4
First added on: May 20, 2024